Literature DB >> 36187313

Asymptomatic myocardial infarction in a patient with myotonic dystrophy type 1.

Yuka Seki1,2, Takanobu Yamada1, Arihiro Kiyosue1, Koichi Kimura3, Masae Uehara1, Masaru Hatano1,4, Takayoshi Sasako5, Yuichiro Shirota6, Atsushi Sudo7, Hiroyuki Ishiura7, Tatsushi Toda7, Toshimasa Yamauchi5, Issei Komuro1.   

Abstract

Myotonic dystrophy type 1 (DM1) displays a wide range of cardiac manifestations, including conduction system disturbances, arrhythmias, and cardiomyopathy. As a result of progressive myocardial injury and fibrosis, patients with DM1 frequently show electrocardiogram (ECG) abnormalities which sometimes cannot be differentiated from myocardial ischemia. Even in DM1 cases with ECG findings indicative of coronary artery disease, coronary angiography and coronary computed tomography often demonstrate intact coronary arteries. In this article, we report a case of a 56-year-old DM1 patient with ST segment change on ECG, who was admitted to our hospital for further examination. Echocardiography revealed severe hypokinesis in the anteroseptal wall and left ventricular thrombus in the apex, suggesting the possibility of an old myocardial infarction in the left anterior descending artery (LAD) region. Coronary computed tomography angiography and coronary angiography demonstrated a severe stenosis suggestive of vulnerable plaque in the proximal part of LAD, although fractional flow reserve of the lesion did not indicate functional ischemia. A beta-blocker and a sodium-glucose cotransporter 2 inhibitor were introduced expecting a cardioprotective effect. One year after his discharge, the patient died of septic and cardiogenic shock triggered by aspiration pneumonia. Learning objective: Although the prevalent cardiac manifestations of patients with myotonic dystrophy type 1 are conduction abnormalities and cardiomyopathy, the possibility of having coronary artery disease should be considered because they often have some atherosclerotic risk factors with their tendency toward metabolic abnormalities such as diabetes mellitus due to insulin resistance and dyslipidemia and with diagnostic difficulty due to asymptomatic or non-specific manifestations.
© 2022 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved. All rights reserved.

Entities:  

Keywords:  Coronary artery disease; Myotonic dystrophy; Neuromuscular cardiomyopathy

Year:  2022        PMID: 36187313      PMCID: PMC9508598          DOI: 10.1016/j.jccase.2022.05.004

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  10 in total

Review 1.  Myotonic dystrophy and the heart.

Authors:  G Pelargonio; A Dello Russo; T Sanna; G De Martino; F Bellocci
Journal:  Heart       Date:  2002-12       Impact factor: 5.994

2.  Non-invasive evaluation of the relationship between electrical and structural cardiac abnormalities in patients with myotonic dystrophy type 1.

Authors:  Lukas Chmielewski; Michael Bietenbeck; Alexandru Patrascu; Sabine Rösch; Udo Sechtem; Ali Yilmaz; Anca-Rezeda Florian
Journal:  Clin Res Cardiol       Date:  2019-02-14       Impact factor: 5.460

3.  Microvascular ischemia in patients with myotonic dystrophy.

Authors:  H Itoh; M Shimizu; Y Horita; H Ino; T Taguchi; K Kajinami; K Yagi; D Chujo; H Mabuchi
Journal:  Jpn Circ J       Date:  2000-09

4.  Increased mortality with left ventricular systolic dysfunction and heart failure in adults with myotonic dystrophy type 1.

Authors:  Deepak Bhakta; Miriam R Groh; Changyu Shen; Robert M Pascuzzi; William J Groh
Journal:  Am Heart J       Date:  2010-12       Impact factor: 4.749

5.  Routine echocardiography in patients with myotonic dystrophy type 1.

Authors:  Teodora Paunic; Stojan Peric; Edita Cvitan; Srdjan Raspopovic; Marina Peric; Gorana Mandic Stojmenovic; Vidosava Rakocevic Stojanovic
Journal:  J Chin Med Assoc       Date:  2017-06-07       Impact factor: 2.743

Review 6.  Cardiovascular manifestations of myotonic dystrophy.

Authors:  Karim Wahbi; Denis Furling
Journal:  Trends Cardiovasc Med       Date:  2019-06-13       Impact factor: 6.677

Review 7.  Myotonic dystrophy and the heart: A systematic review of evaluation and management.

Authors:  J K Lau; R W Sy; A Corbett; L Kritharides
Journal:  Int J Cardiol       Date:  2015-03-05       Impact factor: 4.164

Review 8.  Pathology of the cardiac conduction system in myotonic dystrophy: a study of 12 cases.

Authors:  H H Nguyen; J T Wolfe; D R Holmes; W D Edwards
Journal:  J Am Coll Cardiol       Date:  1988-03       Impact factor: 24.094

9.  Blunted coronary reserve in myotonic dystrophy. An early and gene-related phenomenon.

Authors:  D Annane; P Merlet; H Radvanyi; B Mazoyer; B Eymard; M Fiorelli; C Junien; M Fardeau; Z Ounnoughene; P Gajdos; A Syrota; D Duboc
Journal:  Circulation       Date:  1996-09-01       Impact factor: 29.690

10.  Rare Disease: Cardiac Risk Assessment With MRI in Patients With Myotonic Dystrophy Type 1.

Authors:  Marco Alì; Caterina Beatrice Monti; Luca Melazzini; Rosanna Cardani; Barbara Fossati; Michele Cavalli; Kelvin Chow; Francesco Secchi; Giovanni Meola; Francesco Sardanelli
Journal:  Front Neurol       Date:  2020-03-19       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.